Medicis Announces Approval of New Strengths of SOLODYN(R)

SCOTTSDALE, Ariz., July 27, 2009 (GLOBE NEWSWIRE) — Medicis (NYSE:MRX) today announced that the U.S.

Read the original here:
Medicis Announces Approval of New Strengths of SOLODYN(R)

Related posts:

1. Medicis Announces Approval Of Additional Strengths Of Solodyn(R) Medicis (NYSE:MRX) announced that the U.S. Food and Drug Administration...
2. Medicis and Anacor Enter Into Research and Development Collaboration for the Treatment of Acne SCOTTSDALE, Ariz. and PALO ALTO, Calif., Feb. 10, 2011 (GLOBE...
3. Stiefel, a GSK company, Receives FDA Approval of Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025% Research Triangle Park, N.C. – July 16, 2010 – Stiefel,...
4. Galderma Received FDA Approval Of Differin(R) (adapalene) Lotion, 0.1%, The First Retinoid Available In Lotion Formulation Galderma Laboratories, L.P. announced the U.S...
5. Solta to buy ultrasound fat treatment company from Medicis Solta Medical Inc. will buy all of the outstanding shares...

Leave a comment

Name (required)

E-mail (required)

URI

Your Message